Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

US prescription drugs most expensive in world, analysis shows

May 8, 2019 Research and Development Drug pricing, Japan, Ontario, UK, US, prescription drugs

Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …
News

Number of GPs in decline for first time in 50 years

May 8, 2019 Manufacturing and Production, Research and Development GP, NHS, pharma, public health

The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall …
News
mohammed_dar

Mohammed Dar becomes third MedImmune exec to join Immunocore

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO. Dar …
Appointment
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
Appointment
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
Appointment

Will mobile phones save the NHS?

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …
Feature
shutterstock_232245868

GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3

May 3, 2019 Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma

GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …
News
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …
News
allergan

Allergan shareholders reject proposal to split roles of chairman and CEO

May 2, 2019 Research and Development Allergan, Appaloosa, CEO, board of directors, hedge fund, pharma

Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently …
News

Takeda opens R&D facility in San Diego, California

May 2, 2019 Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …
News

Hormone-based therapies show promise in children and adults with autism

May 2, 2019 Research and Development ASD, autism, pharma, vasopressin

A hormone-based therapy might improve social function in people with autism, according to the results of two separate clinical trials. …
News
40230318504_a38a3dbfde_z

Ambien and other insomnia meds to be labelled with black box warnings after sleepwalking deaths

May 2, 2019 Medical Communications, Research and Development FDA, ambien, black box warning, insomnia, sleeping pills, warning label

The FDA has said that Ambien, and other insomnia medications, must be labelled with a ‘black box warning’ – the …
News

FDA approves AbbVie’s Mavyret for children with Hepatitis C (HCV)

May 1, 2019 Research and Development AbbVie, HCV, hepatitis C, mavyret, pharma

The FDA has approved AbbVie’s Mavyret tables (glecaprevir/pibrentasvir) as a treatment for hepatitis C (HCV) in children aged 12 to 17 …
News
dw-anzcxqaqavhl

FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections

May 1, 2019 Research and Development, Sales and Marketing Contepo, Nabriva, pharma, urinary tract infections

Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026